Baillie Gifford & CO Medifast Inc Transaction History

Baillie Gifford & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$97.09 - $130.31 $1,553 - $2,084	16 Added 11.59%	154 $15,000
Q4 2022 Jan 24, 2023	BUY	$103.38 - $126.05 $1,757 - $2,142	17 Added 14.05%	138 $16,000
Q3 2022 Oct 27, 2022	SELL	$108.36 - $187.67 $1,300 - $2,252	-12 Reduced 9.02%	121 $13,000
Q2 2022 Aug 08, 2022	BUY	$157.78 - $194.92 $2,051 - $2,533	13 Added 10.83%	133 $24,000
Q1 2022 May 05, 2022	BUY	$163.59 - $219.02 $1,635 - $2,190	10 Added 9.09%	120 $20,000
Q3 2021 Oct 19, 2021	SELL	$192.64 - $288.27 $3,660 - $5,477	-19 Reduced 14.73%	110 $21,000
Q2 2021 Aug 02, 2021	SELL	$217.95 - $332.25 $1,089 - $1,661	-5 Reduced 3.73%	129 $37,000
Q1 2021 May 06, 2021	BUY	$192.6 - $274.3 $25,808 - $36,756	134 New	134 $28,000

180

10.4M

554K

545K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $206M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.